Bio-investments
According to the marketing firm Burrill & Company, in 2008, pharmaceutical and biotech companies in the United States spent a record amount on scientific research – $65.2 billion, which is $2 billion. more than in 2007. Of these, about $50.3 billion accounted for pharmaceutical companies, about $14.9 billion. – biotech companies.
A study by the Wharton Business School (Wharton School of the University of Pennsylvania) showed that in 2006, American companies operating in this market spent $65 thousand on scientific research and the introduction of scientific developments into production for each of their employees. This is about 8 times more than the level of similar investments in all other sectors of the US economy.
In general, according to the estimates of the Association of Developers and Manufacturers of Pharmaceutical Products of the USA (Pharmaceutical Research and Manufacturers of America), more than 2.9 thousand new medicines are in the process of testing. Of these, about 750 are designed to fight cancer, more than 300 – with cardiovascular diseases, 150 - with diabetes, about 110 - HIV/AIDS.
Washington ProfilePortal "Eternal youth" www.vechnayamolodost.ru